Clinical Final results as well as Cost-effectiveness associated with Main Prophylaxis involving Febrile Neutropenia In the course of Adjuvant Docetaxel along with Cyclophosphamide Radiation treatment for Cancer of the breast.
https://www.selleckchem.com/pr....oducts/pemigatinib-i